Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Kaj Blennow Henrik Zetterberg Bob Olsson Niklas Mattsson |
| Publication date | November 30, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |